Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer



Status:Completed
Conditions:Dental
Therapuetic Areas:Dental / Maxillofacial Surgery
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:March 2012
End Date:January 2017

Use our guide to learn which trials are right for you!

Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer

The purpose of this study is to determine whether an oral rinse composed of botanical
extracts is effective in the prevention of severe inflammation of the lining of the oral
cavity caused by chemotherapy and radiation therapy for head and neck cancer.


Inclusion Criteria:

- diagnosis of head and neck cancer

- planned treatment course to include Cisplatin and radiation therapy, cumulative
prescription dose between 50-70 Gy

- able to eat at least soft solids

- normal cardiac function

- able to perform oral rinse

Exclusion Criteria:

- Induction chemotherapy regimen

- life threatening allergic reaction to food and/or drugs

- history of any other primary malignancy diagnosed within the past 5 years

- prior radiation to the sites to be treated

- active infections of the oral cavity
We found this trial at
5
sites
Miami, Florida 33136
Principal Investigator: Michael Samuels, MD, FACR
Phone: 305-243-0974
?
mi
from
Miami, FL
Click here to add this to my saved trials
Beer Sheba,
Phone: +972-8-624-4127
?
mi
from
Beer Sheba,
Click here to add this to my saved trials
Gainesville, Florida 32610
Principal Investigator: Robert Amdur, MD
Phone: 352-265-0680
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
New York, New York 10016
?
mi
from
New York, NY
Click here to add this to my saved trials